CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 112 filers reported holding CARDLYTICS INC in Q2 2023. The put-call ratio across all filers is 3.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,028,082 | +86.2% | 320,899 | 0.0% | 0.14% | +51.1% |
| Q1 2023 | $1,089,452 | -75.9% | 320,899 | -58.9% | 0.09% | -76.3% |
| Q4 2022 | $4,512,706 | -64.1% | 780,745 | -41.7% | 0.39% | -62.1% |
| Q3 2022 | $12,581,000 | -57.9% | 1,338,359 | 0.0% | 1.03% | -60.6% |
| Q2 2022 | $29,859,000 | -59.4% | 1,338,359 | 0.0% | 2.60% | -48.3% |
| Q1 2022 | $73,583,000 | -10.5% | 1,338,359 | +7.6% | 5.03% | +12.8% |
| Q4 2021 | $82,233,000 | -21.3% | 1,244,259 | 0.0% | 4.46% | -17.2% |
| Q3 2021 | $104,443,000 | -33.9% | 1,244,259 | 0.0% | 5.39% | -34.5% |
| Q2 2021 | $157,934,000 | +23.0% | 1,244,259 | +6.3% | 8.23% | +13.7% |
| Q1 2021 | $128,377,000 | -2.3% | 1,170,259 | +27.2% | 7.24% | -21.2% |
| Q4 2020 | $131,385,000 | – | 920,259 | – | 9.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
| Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
| CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
| Cannell Capital | 626,975 | $16,289,000 | 4.62% |
| Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
| Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
| Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
| Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
| EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |